These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 3338661)

  • 21. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix.
    Rotmensch J; Senekjian EK; Javaheri G; Herbst AL
    Gynecol Oncol; 1988 Jan; 29(1):76-81. PubMed ID: 3338666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retinoids, cisplatin and interferon-alpha in recurrent or metastatic cervical squamous cell carcinoma: clinical results of 2 phase II trials.
    Braud AC; Gonzague L; Bertucci F; Genre D; Camerlo J; Gravis G; Goncalves A; Moutardier V; Viret F; Maraninchi D; Viens P
    Eur Cytokine Netw; 2002; 13(1):115-20. PubMed ID: 11956030
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma.
    Lele SB; Piver MS
    Gynecol Oncol; 1989 Apr; 33(1):6-8. PubMed ID: 2467845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phase II trial of paclitaxel and cisplatin in metastatic and recurrent carcinoma of the uterine cervix.
    Papadimitriou CA; Sarris K; Moulopoulos LA; Fountzilas G; Anagnostopoulos A; Voulgaris Z; Gika D; Giannakoulis N; Diakomanolis E; Dimopoulos MA
    J Clin Oncol; 1999 Mar; 17(3):761-6. PubMed ID: 10071264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phase II study of carboplatin and liposomal doxorubicin in patients with recurrent squamous cell carcinoma of the cervix.
    Verschraegen CF; Kavanagh JJ; Loyer E; Bodurka-Bevers D; Kudelka AP; Hu W; Vincent M; Nelson T; Levenback C;
    Cancer; 2001 Nov; 92(9):2327-33. PubMed ID: 11745287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of limited small-cell lung cancer with etoposide and cisplatin alternating with vincristine, doxorubicin, and cyclophosphamide versus concurrent etoposide, vincristine, doxorubicin, and cyclophosphamide and chest radiotherapy: a Southwest Oncology Group Study.
    Goodman GE; Crowley JJ; Blasko JC; Livingston RB; Beck TM; Demattia MD; Bukowski RM
    J Clin Oncol; 1990 Jan; 8(1):39-47. PubMed ID: 2153194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A comparison of salvage infusional chemotherapy regimens for recurrent/refractory multiple myeloma.
    Griffin PT; Ho VQ; Fulp W; Nishihori T; Shain KH; Alsina M; Baz RC
    Cancer; 2015 Oct; 121(20):3622-30. PubMed ID: 26149422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in the treatment of metastatic carcinoma of the uterine cervix.
    Papadimitriou CA; Dimopoulos MA; Giannakoulis N; Sarris K; Vassilakopoulos G; Akrivos T; Voulgaris Z; Vlahos G; Diakomanolis E; Michalas S
    Cancer; 1997 Jun; 79(12):2391-5. PubMed ID: 9191528
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Combination of consecutive low-dose cisplatin with bleomycin, vincristine, and mitomycin for recurrent cervical carcinoma.
    Shimizu Y; Akiyama F; Umezawa S; Ishiya T; Utsugi K; Hasumi K
    J Clin Oncol; 1998 May; 16(5):1869-78. PubMed ID: 9586903
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methyl-CCNU, doxorubicin, and cis-diamminedichloroplatinum II in the management of recurrent and metastatic squamous carcinoma of the cervix.
    Carlson JA; Day TG; Allegra JC; Woodcock TM; Greenberg RA; Masterson BJ
    Cancer; 1984 Jul; 54(2):211-4. PubMed ID: 6539161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of cisplatin, doxorubicin, and cyclophosphamide to treat advanced and recurrent adenocarcinoma of the endometrium.
    Hancock KC; Freedman RS; Edwards CL; Rutledge FN
    Cancer Treat Rep; 1986 Jun; 70(6):789-91. PubMed ID: 3731140
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II study of tirapazamine plus cisplatin in patients with advanced or recurrent cervical cancer.
    Maluf FC; Leiser AL; Aghajanian C; Sabbatini P; Pezzulli S; Chi DS; Wolf JK; Levenback C; Loh E; Spriggs DR
    Int J Gynecol Cancer; 2006; 16(3):1165-71. PubMed ID: 16803501
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dual sequential non-cross-resistant chemotherapy for advanced stage squamous cell carcinoma of the cervix.
    Levi JA; Wheeler HR; Friedlander M; Tattersall MH; Kefford R; Dalley D
    Gynecol Oncol; 1992 Jun; 45(3):329-33. PubMed ID: 1377155
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Response to Combination Chemotherapy With Paclitaxel/Ifosfamide/Platinum Versus Paclitaxel/Platinum for Patients With Metastatic, Recurrent, or Persistent Carcinoma of the Uterine Cervix: A Retrospective Analysis.
    Choi HJ; Paik ES; Choi CH; Kim TJ; Lee YY; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2018 Sep; 28(7):1333-1341. PubMed ID: 30045137
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Doxorubicin and cisplatin for recurrent or metastatic squamous cell carcinoma of the head and neck.
    Sandler S; Bonomi P; Taylor B; Showel J; Slayton R; Lerner H
    Cancer Treat Rep; 1984 Sep; 68(9):1163-5. PubMed ID: 6541095
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bleomycin-adriamycin-cisplatin combination chemotherapy in the treatment of primary advanced and recurrent cervical carcinoma.
    Sorbe B; Frankendal B
    Obstet Gynecol; 1984 Feb; 63(2):167-70. PubMed ID: 6198610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Induction with mitomycin C, doxorubicin, cisplatin and maintenance with weekly 5-fluorouracil, leucovorin for treatment of metastatic nasopharyngeal carcinoma: a phase II study.
    Hong RL; Sheen TS; Ko JY; Hsu MM; Wang CC; Ting LL
    Br J Cancer; 1999 Aug; 80(12):1962-7. PubMed ID: 10471046
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective treatment of advanced or recurrent endometrial carcinoma with cisplatin, doxorubicin, and cyclophosphamide.
    Burke TW; Stringer CA; Morris M; Freedman RS; Gershenson DM; Kavanagh JJ; Edwards CL
    Gynecol Oncol; 1991 Mar; 40(3):264-7. PubMed ID: 2013451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A phase II study of 5-fluorouracil/cisplatin in recurrent cervical cancer].
    Kaern J; Tropé C; Kjørstad KE; Nordal R; Sundfør K; Vergote I; Vossli S; Abeler V; Sandvei R
    Tidsskr Nor Laegeforen; 1990 Sep; 110(21):2759-62. PubMed ID: 2219049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multimodal therapy including neoadjuvant methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) for stage IIB to IV cervical cancer.
    Dowdy SC; Boardman CH; Wilson TO; Podratz KC; Hartmann LC; Long HJ
    Am J Obstet Gynecol; 2002 Jun; 186(6):1167-73. PubMed ID: 12066092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.